Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea

被引：0
|
作者：
Sclar, David Alexander [1 ]
Robison, Linda M. [1 ]
Oganov, Ambartsum M. [1 ]
Schmidt, Jennifer M. [1 ]
Bowan, Kurt A. [1 ]
Castillo, Leigh V. [1 ]
机构：
[1] Midwestern Univ, Coll Pharm, Glendale, AZ USA
来源：
CLINICAL DRUG INVESTIGATION | 2013年 / 33卷 / 03期
关键词：
Public Health; Internal Medicine; Vancomycin; Healthcare System; Metronidazole;
D O I：
10.1007/s40261-013-0059-z
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [41] Clostridium difficile-associated diarrhea in cancer patients treated with fidaxomicin or vancomycin.
    Cornely, Oliver A.
    Miller, Mark
    Fantin, Bruno
    Mullane, Kathleen M.
    Kean, Yin
    Gorbach, Sherwood
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Choice of treatment in Clostridium difficile-associated diarrhoea: Clinical practice guidelines or risk classifications
    Lleti, Miguel Salavert
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2017, 35 (10): : 613 - 616
  • [43] Is Fidaxomicin the Drug of Choice for Treating Clostridium difficile-Associated Diarrhea in Patients With Cancer?
    Green, Myke R.
    Acharya, Utkarsh H.
    Yeager, Andrew M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4376 - 4378
  • [44] Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage
    Bauer, M. P.
    Goorhuis, A.
    Koster, T.
    Numan-Ruberg, S. C.
    Hagen, E. C.
    Debast, S. B.
    Kuijper, E. J.
    van Dissel, J. T.
    NETHERLANDS JOURNAL OF MEDICINE, 2008, 66 (05): : 207 - 211
  • [45] Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital
    Changela, U
    Cannon, JP
    Aneziokoro, C
    Shah, PS
    Thottapurathu, L
    Lentino, J
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (06) : 562 - 566
  • [46] Treatment of recurrent Clostridium difficile-associated disease
    Christina M Surawicz
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 32 - 38
  • [47] Do statins protect against the development of Clostridium difficile-associated diarrhoea?
    Nseir, William
    Bishara, Jihad
    Mograbi, Julnar
    Mahamid, Mahmud
    Khalaila, Wissam
    Taha, Muhammad
    Farah, Raymond
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (08) : 1889 - 1893
  • [48] Clostridium difficile-associated diarrhoea in a tertiary referral neurocritical care centre
    S Tripathy
    C Kataria
    PV Nair
    Critical Care, 15 (Suppl 1):
  • [49] Treatment of recurrent Clostridium difficile-associated disease
    Surawicz, Christina M.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (01): : 32 - 38
  • [50] Bezlotoxumab for the treatment of Clostridium difficile-associated diarrhea
    Thakare, R.
    Dasgupta, A.
    Chopra, S.
    DRUGS OF TODAY, 2017, 53 (07) : 385 - 392
12345